Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: A pilot implementation study

Journal of Rheumatology

Volumn 36, Issue 7, 2009, Pages 1380-1386

  Van Tuyl, Lilian H D ^a   Plass, Anne Marie C ^a   Lems, Willem F ^a   Voskuyl, Alexandre E ^a   Kerstens, Pit J S M ^a   Dijkmans, Ben A C ^a   Boers, Maarten ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

Combination drug therapy; Implementation research; Nursing education research; Rheumatoid arthritis

Indexed keywords

INFLIXIMAB; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COBRA COMBINATION THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; EARLY RHEUMATOID ARTHRITIS; EDUCATION PROGRAM; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NETHERLANDS; NURSE ATTITUDE; PATIENT SATISFACTION; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUGS, GENERIC; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PILOT PROJECTS; PREDNISOLONE; QUESTIONNAIRES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 67650499608     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081078     Document Type: Article

References (19)

1. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
2. Dougados M, Combe B, Cantagrel A, et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999;58:220-5.
3. Mottonen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73.
4. O'Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
5. Capell HA, Madhok R, Porter DR, et al. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Ann Rheum Dis 2007;66:235-41.
6. Lehman AJ, Esdaile JM, Klinkhoff AV, Grant E, Fitzgerald A, Canvin J. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum 2005;52:1360-70.
7. Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
8. Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007;146:406-15.
9. Korthals-de Bos IBC, van Tulder MW, Boers M, et al. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol 2004;3:1709-16.
10. Verhoeven AC, Bibo JC, Boers M, Engel GL, van der Linden S. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis. Br J Rheumatol 1998;37:1102-9.
11. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care 2001;39 Suppl:II2-45.
12. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001;286:2578-85.
13. COBRA therapy.nl. Amsterdam: VU University Medical Center and the Jan van Breemen Institute; 2008. [Internet. Accessed March 6, 2009] Available from: http://www.cobratherapy.nl
14. van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Dijkmans BA, Boers M. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? Ann Rheum Dis 2007;66:974-6.
15. van Tuyl LHD, Plass AMC, Lems WF, et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology 2008;47:1571-6. Epub 2008 Aug 18.
16. Ajzen I. Attitudes, personality and behaviour. London: Open University Press; 1988.
17. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998;317:858-61.
18. Rogers E. Diffusion of innovations. New York: Free Press; 1983.
19. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med 2005;142:891-7.